MN SF3822

Increases the maximum medical cannabis supply that may be distributed to patients from a 30-day supply to a 120-day supply of the dosage determined for that patient.

Requires licensed pharmacists employed by manufacturers to provide final approval for all medical cannabis distributions to patients.

Mandates pharmacist consultation with patients to determine proper dosage based on chemical composition ranges and dosage recommendations reported by the commissioner, with allowance for remote videoconference consultations at distribution facilities.

Requires proper packaging compliant with the United States Poison Prevention Packing Act and labeling with patient information including name, date of birth, registry identification number, chemical composition, and dosage.

Mandates assignment of tracking numbers to all medical cannabis distributed and requires employees transporting medical cannabis to carry manufacturer identification.